Use of chronic irritative foci in laboratory evaluation of antiepileptic drugs.
D000535:Aluminum; D000613:Aminobutyrates / Q000008:administration & dosage*; D000818:Animals; D001534:Bemegride; D000697:Central Nervous System Stimulants; D002707:Chlordiazepoxide / Q000008:administration & dosage*; D002746:Chlorpromazine / Q000008:administration & dosage; D003975:Diazepam / Q000008:administration & dosage*; D004155:Diphenhydramine; D004569:Electroencephalography; D004987:Ethers; D005461:Fluorine; D000882:Haplorhini; D006878:Hydroxides; D006898:Hydroxylamines; D007531:Isoflurophate; D010433:Pentylenetetrazole; D010852:Picrotoxin; D011736:Pyridoxine / Q000008:administration & dosage*; D012110:Reserpine / Q000008:administration & dosage*; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy*; D012663:Semicarbazides; D013331:Strychnine
D000535:Aluminum; D000613:Aminobutyrates; D001534:Bemegride; D000697:Central Nervous System Stimulants; D002707:Chlordiazepoxide; D002746:Chlorpromazine; D003975:Diazepam; D004155:Diphenhydramine; D004987:Ethers; D005461:Fluorine; D006878:Hydroxides; D006898:Hydroxylamines; D007531:Isoflurophate; D010433:Pentylenetetrazole; D010852:Picrotoxin; D011736:Pyridoxine; D012110:Reserpine; D012663:Semicarbazides; D013331:Strychnine